TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BBIO

BridgeBio Pharma Inc

Healthcare · Biotechnology

66.30$ +0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,217 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BBIO
Line item Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 465 401 326 641 632 990 905 788 704 1,093 1,081 782 1,013 813 862 729 623 626 504 655 546 849 794 665 919 882 1,080 998 936 1,371 1,217
92 – – 445 382 307 558 569 925 862 745 643 945 910 640 889 716 771 642 549 553 433 588 478 783 616 445 721 695 912 839 754 1,178 1,093
-92 – – 436 373 294 414 364 757 541 367 356 471 379 180 394 372 470 483 377 433 302 505 376 475 547 266 681 541 749 643 570 880 678
92 – – 436 373 294 536 546 905 841 711 607 919 838 600 837 671 716 592 472 517 384 543 435 520 587 266 681 541 757 646 587 940 720
– – – – – – – 2.8 – – 8.0 – 0.5 46 8.2 20 11 23 25 17 11 8.6 5.2 1.8 235 0.7 0.5 4.7 115 77 117 139 205 254
– – – – – – – -2.8 – – – – – 1.2 – 0.0 – 0.0 – 38 26 20 17 17 – -28 – 0.0 4.0 18 25 27 33 53
– – – – 1.9 1.9 3.0 5.6 25 26 26 20 23 42 28 46 17 30 16 15 14 23 – – – – – – – – – – – –
– – – – – – – – – – – – – – 46 45 30 30 29 29 28 28 27 26 26 25 25 24 28 30 29 28 27 27
– – – 566 91 593 116 156 538 578 569 596 1,481 1,537 1,517 1,878 1,854 1,877 1,859 1,868 1,839 1,853 1,849 1,889 1,886 1,876 1,883 2,377 2,520 2,859 2,921 3,013 3,640 3,723
– – – 33 35 39 40 60 65 93 76 96 95 132 96 135 103 141 119 121 97 110 106 144 141 134 139 154 152 176 217 288 816 891
– – – – – – – 8.0 2.5 3.6 3.6 5.3 11 4.8 5.3 4.9 4.4 4.3 4.0 3.7 3.7 3.8 4.1 4.1 4.5 4.6 4.6 4.5 5.2 14 5.3 17 573 551
– – – 14 12 16 10 8.9 13 13 9.8 8.9 10 22 12 12 10 8.8 10 12 4.1 3.9 4.5 11 4.7 18 13 9.6 28 26 19 36 29 27
– – – – 55 75 75 92 461 467 472 476 1,361 1,374 1,375 1,704 1,708 1,693 1,699 1,708 1,713 1,719 1,721 1,727 1,716 1,718 1,719 1,721 1,848 1,850 1,851 1,852 1,926 1,928
86 – – -164 252 -316 460 408 381 266 164 58 -395 -464 -743 -870 -1,041 -1,026 -1,138 -1,255 -1,226 -1,362 -1,208 -1,354 -1,050 -1,093 -1,230 -1,468 -1,648 -1,788 -1,933 -2,077 -2,269 -2,515
– – – -171 -235 -326 -367 -440 -532 -653 -769 -889 -1,038 -1,134 -1,290 -1,437 -1,633 -1,643 -1,781 -1,918 -2,057 -2,215 -2,392 -2,561 -2,596 -2,669 -2,831 -3,096 -3,264 -3,446 -3,628 -3,821 -3,985 -4,137
92 92 92 92 120 93 117 118 118 117 118 119 139 147 147 145 146 147 148 149 153 161 163 174 179 188 189 189 190 191 191 197 195 196

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?